Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast effects on cognition in healthy adults
2011-002070-23Phase 2Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of roflumilast, sponsored by Maastricht University Medical Center+. Primary endpoints: Declarative episodic memory performance, Object relocation task performance and 3 more. Started Jun 2011; status: terminated.
02
Drugs
roflumilast
Beyond the preview
Go deeper on 2011-002070-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002070-23.